Literature DB >> 15830063

Intrinsic tectal low grade astrocytomas: is surgical removal an alternative treatment? Long-term outcome of eight cases.

Ricardo Ramina1, Mauricio Coelho Neto, Yvens Barbosa Fernandes, Guilherme Borges, Donizeti Cesar Honorato, Walter Oleschko Arruda.   

Abstract

Low-grade gliomas arising in dorsal midbrain in children and young patients usually present few neurological symptoms and findings, and patients management is controversial. Some authors propose only clinical observation until the patient present signs of increased intracranial pressure when a shunt with or without biopsy, is inserted; others recommend radiotherapy after stereotactic or open biopsy. Microsurgical total removal of tumor may be curative. We present a retrospective analysis of eight patients (mean age 16.6 +/- 11.5 years-old) with low-grade astrocytoma of the tectal region operated on using an infratentorial/supracerebellar approach between 1981 and 2002. All patients presented hydrocephalus and had a shunt insertion before surgical resection of the lesion. The tumour could be totally resected in seven patients. In one case radical removal was not possible due to infiltrative pattern of the lesion. Postoperative radiotherapy was performed in two cases, one patient at the beginning of this series and in the case with infiltrative tumor. This patient presented progressive tumor growth and died five years after surgery. No recurrence occurred after total removal. Post-surgical follow-up time ranged from 2 1/2 to 22 1/2 years (mean 9.9 +/- 5.9 years). Radical microsurgical removal of non invasive tumors is possible without mortality or significant morbidity. It may be curative and should remain as an alternative to be discussed with the patient.

Entities:  

Mesh:

Year:  2005        PMID: 15830063     DOI: 10.1590/s0004-282x2005000100008

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  5 in total

1.  Pediatric tectal plate gliomas: a review of clinical outcomes, endocrinopathies, and neuropsychological sequelae.

Authors:  David Gass; Mariko Dewire; Lionel Chow; Susan R Rose; Sarah Lawson; Charles Stevenson; Ahna L H Pai; Blaise Jones; Mary Sutton; Adam Lane; David Pruitt; Maryam Fouladi; Trent R Hummel
Journal:  J Neurooncol       Date:  2015-01-13       Impact factor: 4.130

2.  Brevican, neurocan, tenascin-C and versican are mainly responsible for the invasiveness of low-grade astrocytoma.

Authors:  Imre Varga; Gábor Hutóczki; Csaba D Szemcsák; Gábor Zahuczky; Judit Tóth; Zsolt Adamecz; Annamária Kenyeres; László Bognár; Zoltán Hanzély; Almos Klekner
Journal:  Pathol Oncol Res       Date:  2011-10-14       Impact factor: 3.201

Review 3.  Pediatric low-grade gliomas: how modern biology reshapes the clinical field.

Authors:  Guillaume Bergthold; Pratiti Bandopadhayay; Wenya Linda Bi; Lori Ramkissoon; Charles Stiles; Rosalind A Segal; Rameen Beroukhim; Keith L Ligon; Jacques Grill; Mark W Kieran
Journal:  Biochim Biophys Acta       Date:  2014-02-28

4.  Diagnostic challenges, management and outcomes of midline low-grade gliomas.

Authors:  Mueez Waqar; Shahid Hanif; Nitika Rathi; Kumar Das; Rasheed Zakaria; Andrew R Brodbelt; Carol Walker; Michael D Jenkinson
Journal:  J Neurooncol       Date:  2014-08-06       Impact factor: 4.130

5.  Tectal glioma as a distinct diagnostic entity: a comprehensive clinical, imaging, histologic and molecular analysis.

Authors:  Anthony P Y Liu; Julie H Harreld; Lisa M Jacola; Madelyn Gero; Sahaja Acharya; Yahya Ghazwani; Shengjie Wu; Xiaoyu Li; Paul Klimo; Amar Gajjar; Jason Chiang; Ibrahim Qaddoumi
Journal:  Acta Neuropathol Commun       Date:  2018-09-25       Impact factor: 7.801

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.